{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3"}]}],"title":"Abdominal pain"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Acute kidney injury"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"title":"Lymphocyte count decrease"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Iincrease in alanine aminotransferase"},{"categories":[{"measurements":[{"groupId":"OG000","value":"58"}]}],"title":"Neutrophil count decrease"},{"categories":[{"measurements":[{"groupId":"OG000","value":"10"}]}],"title":"Anemia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Increase in aspartate aminotransferase"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Catheter related infection"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Constipation"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Dehydration"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Encephalopathy"},{"categories":[{"measurements":[{"groupId":"OG000","value":"9"}]}],"title":"Febrile neutropenia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"3"}]}],"title":"Fever"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Hyperglycemia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Hyperkalemia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"title":"Hypocalcemia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Hypokalemia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Hypomagnesemia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Hyponatremia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"6"}]}],"title":"Hypophosphatemia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Small intestine obstruction"},{"categories":[{"measurements":[{"groupId":"OG000","value":"5"}]}],"title":"Nausea"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Non-cardiac chest pain"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Other gastrointestinal disorders"},{"categories":[{"measurements":[{"groupId":"OG000","value":"10"}]}],"title":"Other infection"},{"categories":[{"measurements":[{"groupId":"OG000","value":"7"}]}],"title":"Platelet count decrease"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Syncope"},{"categories":[{"measurements":[{"groupId":"OG000","value":"4"}]}],"title":"Vomiting"},{"categories":[{"measurements":[{"groupId":"OG000","value":"17"}]}],"title":"White blood cell decrease"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Wound infection"}],"denoms":[{"counts":[{"groupId":"OG000","value":"182"}],"units":"Participants"}],"description":"The number of patients assigned to receive chemotherapy that experience CTC Version 4 grade 3 or higher at any time during protocol therapy","groups":[{"description":"Experimental","id":"OG000","title":"Arm I"}],"paramType":"NUMBER","populationDescription":"182 patients were enrolled on intermediate risk chemotherapy and were evaluable for this secondary endpoint","reportingStatus":"POSTED","timeFrame":"Up to 126 days after the start of chemotherapy","title":"Toxicity Associated With Chemotherapy: Grade 3 or Higher. Toxicity as Assessed by the Common Terminology Criteria for Adverse Events (CTCAE) v4.0","type":"SECONDARY","unitOfMeasure":"patients"}